BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/14/2026 8:58:01 AM | Browse: 2 | Download: 21
 |
Received |
|
2025-11-28 01:15 |
|
Peer-Review Started |
|
2025-12-01 09:05 |
|
First Decision by Editorial Office Director |
|
2025-12-30 05:58 |
|
Return for Revision |
|
2025-12-30 05:58 |
|
Revised |
|
2026-01-08 21:57 |
|
Publication Fee Transferred |
|
2026-01-13 11:07 |
|
Second Decision by Editor |
|
2026-02-04 02:56 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-11 06:25 |
|
Articles in Press |
|
2026-02-11 06:25 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-04-01 06:03 |
|
Publish the Manuscript Online |
|
2026-04-14 08:58 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Observational Study |
| Article Title |
Product of C-reactive protein and fasting C-peptide indicates cardiovascular risk in type 2 diabetes: A real-world study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ya-Wen Zhang, Man-Rong Xu, Meng-Han Li and Lian-Xi Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81770813 |
| National Natural Science Foundation of China |
82070866 |
| the National Key Research and Development Plan |
2018YFC1314905 |
|
| Corresponding Author |
Lian-Xi Li, MD, PhD, Department of Endocrinology and Metabolism, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, 600 Yishan Road, Shanghai 200233, China. lilx@sjtu.edu.cn |
| Key Words |
Type 2 diabetes mellitus; C-reactive protein; C-peptide; Cardiovascular diseases; Risk factor; Real-world study |
| Core Tip |
This study introduces the product of C-reactive protein and fasting C-peptide as a novel composite indicator. It better reflects the combined effects of inflammation and insulin resistance and shows more stable associations with cardiovascular and cerebrovascular events than either component alone in patients with type 2 diabetes mellitus, supporting its potential value as a composite marker reflecting the overall cardiovascular risk burden. |
| Publish Date |
2026-04-14 08:58 |
| Citation |
Zhang YW, Xu MR, Li MH, Li LX. Product of C-reactive protein and fasting C-peptide indicates cardiovascular risk in type 2 diabetes: A real-world study. World J Diabetes 2026; 17(4): 117063 |
| URL |
https://www.wjgnet.com/1948-9358/full/v17/i4/117063.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v17.i4.117063 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
